Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thrombophilia × Injections × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 45 Breast Neoplasms 20 Myelodysplastic Syndromes 19 Prostatic Neoplasms 12 Neoplasms 12 Leukemia, Myelomonocytic, Chronic 12 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Multiple Myeloma 6 Esophageal Neoplasms 6 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Lung Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Cholangiocarcinoma 4

Interventions

enoxaparin sodium 1 Observation 1 Lead 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡